198 related articles for article (PubMed ID: 22370327)
1. A way forward on the medically appropriate use of white cell growth factors.
Smith TJ; Hillner BE
J Clin Oncol; 2012 May; 30(14):1584-7. PubMed ID: 22370327
[No Abstract] [Full Text] [Related]
2. The role of mini-allotransplants in the treatment of solid tumors.
Schouten HC
Ann Oncol; 2002; 13 Suppl 4():281-6. PubMed ID: 12401702
[No Abstract] [Full Text] [Related]
3. High-dose chemotherapy for breast cancer.
Nieto Y; Shpall EJ
Cancer Treat Res; 2000; 103():77-114. PubMed ID: 10948443
[No Abstract] [Full Text] [Related]
4. Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma.
Johnston LJ; Stockerl-Goldstein KE; Hu WW; Negrin RS; Hoppe RT; Blume KG; Horning SJ
Biol Blood Marrow Transplant; 2000; 6(5A):555-62. PubMed ID: 11071261
[TBL] [Abstract][Full Text] [Related]
5. [Not Available].
Zschaeck S; Baumann M
Strahlenther Onkol; 2016 Sep; 192(9):675-6. PubMed ID: 27402387
[No Abstract] [Full Text] [Related]
6. Status of high-dose chemotherapy for breast cancer: a review.
Nieto Y; Champlin RE; Wingard JR; Vredenburgh JF; Elias AD; Richardson P; Glaspy J; Jones RB; Stiff PJ; Bearman SI; Cagnoni PJ; McSweeney PA; LeMaistre CF; Pecora AL; Shpall EF
Biol Blood Marrow Transplant; 2000; 6(5):476-95. PubMed ID: 11063377
[TBL] [Abstract][Full Text] [Related]
7. High-dose ifosfamide/carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusion.
Fields KK; Elfenbein GJ; Perkins JB; Janssen WE; Ballester OF; Hiemenz JW; Zorsky PE; Kronish LE; Foody MC
Semin Oncol; 1994 Oct; 21(5 Suppl 12):86-92. PubMed ID: 7527592
[TBL] [Abstract][Full Text] [Related]
8. [High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].
Jost LM; Honegger HP; Stahel RA
Schweiz Med Wochenschr; 2000 Jan; 130(3):60-9. PubMed ID: 10683881
[TBL] [Abstract][Full Text] [Related]
9. The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.
Elias AD; Ibrahim J; Richardson P; Avigan D; Joyce R; Reich E; McCauley M; Wheeler C; Frei E
Biol Blood Marrow Transplant; 2002; 8(4):198-205. PubMed ID: 12017145
[TBL] [Abstract][Full Text] [Related]
10. Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.
Golden EB; Chhabra A; Chachoua A; Adams S; Donach M; Fenton-Kerimian M; Friedman K; Ponzo F; Babb JS; Goldberg J; Demaria S; Formenti SC
Lancet Oncol; 2015 Jul; 16(7):795-803. PubMed ID: 26095785
[TBL] [Abstract][Full Text] [Related]
11. [From bone marrow transplantation to blood stem cell transplantation. Experiences from the first 100 autologous stem cell transplantation in Turku].
Remes K; Rajamäki A; Grenman S; Itälä M; Kauppila M; Nikoskelainen J; Pelliniemi TT; Ristamäki R; Salmi TT; Salmi T; Salminen E; Vanharanta R; Toivanen A
Duodecim; 1997; 113(3):219-28. PubMed ID: 11370030
[No Abstract] [Full Text] [Related]
12. Rapid delivery of multiple high-dose chemotherapy courses with granulocyte colony-stimulating factor and peripheral blood-derived hematopoietic progenitor cells.
Crown J; Wassherheit C; Hakes T; Fennelly D; Reich L; Moore M; Schneider J; Curtin J; Rubin SC; Reichman B
J Natl Cancer Inst; 1992 Dec; 84(24):1935-6. PubMed ID: 1281238
[No Abstract] [Full Text] [Related]
13. Peripheral blood progenitor cell transplantation for breast cancer: pharmacoeconomic considerations.
Gilbert CJ
Pharmacotherapy; 1996; 16(3 Pt 2):101S-108S. PubMed ID: 8726589
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors.
McGuire WP
Curr Probl Cancer; 1998; 22(3):135-77. PubMed ID: 9659570
[TBL] [Abstract][Full Text] [Related]
15. [Peripheral blood stem cell transplantation: current status and perspectives].
Colombat P
Bull Cancer; 1995; 82 Suppl 1():42s-48s. PubMed ID: 7542943
[TBL] [Abstract][Full Text] [Related]
16. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
[TBL] [Abstract][Full Text] [Related]
17. Short- and long-term safety of the 2 x 10(6) CD34+ cells/kg threshold for hematopoietic reconstitution after high-dose chemotherapy and peripheral blood progenitor cell support.
Corsini C; Bertolini F; Mancuso P; Cinieri S; Peccatori F; Martinelli G
Ann Oncol; 2002 Jun; 13(6):983-5. PubMed ID: 12123347
[No Abstract] [Full Text] [Related]
18. Marginal benefit/disadvantage of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in children: results of a prospective randomized trial. The Japanese Cooperative Study Group of PBSCT.
Kawano Y; Takaue Y; Mimaya J; Horikoshi Y; Watanabe T; Abe T; Shimizu Y; Matsushita T; Kikuta A; Watanabe A; Iwai A; Ito E; Endo M; Kodani N; Ohta S; Gushi K; Azuma H; Etoh T; Okamoto Y; Amano K; Hattori H; Eguchi H; Kuroda Y
Blood; 1998 Dec; 92(11):4040-6. PubMed ID: 9834207
[TBL] [Abstract][Full Text] [Related]
19. [Intensive chemotherapy with hematopoietic stem cell autograft in solid malignant tumors in children: current evaluation and prespectives].
Sommelet D
Arch Pediatr; 1996 Jul; 3(7):643-8. PubMed ID: 8881173
[No Abstract] [Full Text] [Related]
20. Intensive cyclic chemotherapy and transplantation of autologous peripheral blood progenitor cells (PBPC) or whole blood in high-risk breast cancer - follow up at 10 years.
Cinek P; Filip S; Vanasek J; Mericka P; Blaha M; Zouhar M
Exp Oncol; 2007 Jun; 29(2):144-51. PubMed ID: 17704748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]